Trgovina Nautilus Biotechnology, Inc. - NAUT CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | - | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | N/A |
| Odpri* | N/A |
| Enoletna sprememba* | N/A |
| Dnevni razpon* | N/A |
| Razpon 52 wk | 1.50-5.07 |
| Povprečni obseg (10 dni) | 210.16K |
| Povprečni obseg (3 meseci) | 2.72M |
| Tržna kapitalizacija | 313.42M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 124.87M |
| Prihodki | N/A |
| EPS | -0.46 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|
Nautilus Biotechnology, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 63.618 | 50.498 | 15.744 | 10.11 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 25.946 | 21.146 | 3.312 | 1.622 |
| Raziskave in razvoj | 36.472 | 28.352 | 12.432 | 8.488 |
| Prihodki iz poslovanja | -63.618 | -50.498 | -15.744 | -10.11 |
| Drugo, neto | -0.122 | 0.183 | 0.125 | 0.492 |
| Čisti dobiček pred obdavčitvijo | -57.924 | -50.315 | -15.619 | -9.618 |
| Čisti dobiček po davkih | -57.924 | -50.315 | -15.619 | -9.618 |
| Čisti dobiček pred dodatnimi postavkami | -57.924 | -50.315 | -15.619 | -9.618 |
| Čisti dobiček | -57.924 | -50.315 | -15.619 | -9.618 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -57.924 | -50.315 | -15.619 | -9.618 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -57.924 | -50.315 | -15.619 | -9.618 |
| Popravljen čisti dobiček | -57.924 | -50.315 | -15.619 | -9.618 |
| Popravljene ponderirane povprečne delnice | 124.59 | 124.303 | 124.094 | 124.094 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.46492 | -0.40478 | -0.12586 | -0.07751 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.46492 | -0.40478 | -0.12586 | -0.07751 |
| Depreciation / Amortization | 1.2 | 1 | ||
| Prihodki (odhodki) od obresti, neto Neoperativni | 5.816 |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 16.304 | 15.82 | 15.472 | 16.022 | 16.816 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 6.717 | 6.249 | 6.616 | 6.364 | 6.923 |
| Raziskave in razvoj | 9.587 | 9.571 | 8.856 | 9.658 | 9.893 |
| Prihodki iz poslovanja | -16.304 | -15.82 | -15.472 | -16.022 | -16.816 |
| Drugo, neto | 0.009 | -0.132 | 0.783 | 0.259 | 0.127 |
| Čisti dobiček pred obdavčitvijo | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Čisti dobiček po davkih | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Čisti dobiček pred dodatnimi postavkami | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Čisti dobiček | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Popravljen čisti dobiček | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 |
| Popravljene ponderirane povprečne delnice | 124.792 | 124.651 | 124.494 | 124.419 | 124.303 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.10745 | -0.11282 | -0.11799 | -0.12669 | -0.13426 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.10745 | -0.11282 | -0.11799 | -0.12669 | -0.13426 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 2.886 | 1.889 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Kratkoročna sredstva skupaj | 349.222 | 77.659 | 16.964 |
| Denarna sredstva in kratkoročne naložbe | 345.729 | 76.742 | 16.659 |
| Denarna sredstva in ustrezniki | 185.619 | 36.607 | 0.595 |
| Kratkoročne naložbe | 160.11 | 40.135 | 16.064 |
| Prepaid Expenses | 3.493 | 0.917 | 0.305 |
| Total Assets | 398.45 | 85.011 | 18.542 |
| Property/Plant/Equipment, Total - Net | 31.86 | 6.213 | 1.119 |
| Property/Plant/Equipment, Total - Gross | 33.854 | 7.498 | 1.868 |
| Accumulated Depreciation, Total | -1.994 | -1.285 | -0.749 |
| Other Long Term Assets, Total | 0.997 | 1.139 | 0.459 |
| Total Current Liabilities | 5.812 | 3.018 | 0.49 |
| Accounts Payable | 1.723 | 0.47 | 0.289 |
| Accrued Expenses | 4.089 | 2.548 | 0.201 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Total Liabilities | 34.874 | 6.314 | 0.49 |
| Total Long Term Debt | 0 | 0 | 0 |
| Other Liabilities, Total | 29.062 | 3.296 | 0 |
| Total Equity | 363.576 | 78.697 | 18.052 |
| Preferred Stock - Non Redeemable, Net | 0 | 108.418 | 32.561 |
| Common Stock | 0.012 | 0.001 | 0.001 |
| Additional Paid-In Capital | 444.388 | 0.6 | 0.189 |
| Retained Earnings (Accumulated Deficit) | -80.64 | -30.325 | -14.706 |
| Other Equity, Total | -0.184 | 0.003 | 0.007 |
| Total Liabilities & Shareholders’ Equity | 398.45 | 85.011 | 18.542 |
| Total Common Shares Outstanding | 124.303 | 124.094 | 124.094 |
| Long Term Investments | 16.371 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 327.065 | 349.222 | 352.222 | 374.628 | 69.445 |
| Denarna sredstva in kratkoročne naložbe | 324.117 | 345.729 | 347.345 | 373.144 | 67.837 |
| Denarna sredstva in ustrezniki | 188.622 | 185.619 | 190.241 | 288.387 | 51.803 |
| Kratkoročne naložbe | 135.495 | 160.11 | 157.104 | 84.757 | 16.034 |
| Prepaid Expenses | 2.948 | 3.493 | 4.877 | 1.484 | 1.608 |
| Total Assets | 384.673 | 398.45 | 385.347 | 393.275 | 76.148 |
| Property/Plant/Equipment, Total - Net | 31.693 | 31.86 | 5.731 | 2.769 | 2.889 |
| Property/Plant/Equipment, Total - Gross | 33.968 | 33.854 | 7.772 | 4.533 | 4.388 |
| Accumulated Depreciation, Total | -2.275 | -1.994 | -2.041 | -1.764 | -1.499 |
| Other Long Term Assets, Total | 0.997 | 0.997 | 0.767 | 0.612 | 3.814 |
| Total Current Liabilities | 6.406 | 5.812 | 4.209 | 3.231 | 4.525 |
| Accounts Payable | 1.487 | 1.723 | 1.498 | 1.229 | 2.12 |
| Accrued Expenses | 4.919 | 4.089 | 2.711 | 2.002 | 2.405 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 34.964 | 34.874 | 7.5 | 3.231 | 4.525 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 28.558 | 29.062 | 3.291 | 0 | 0 |
| Total Equity | 349.709 | 363.576 | 377.847 | 390.044 | 71.623 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 108.418 | ||
| Common Stock | 0.012 | 0.012 | 0.012 | 0.012 | 0.001 |
| Additional Paid-In Capital | 446.654 | 444.388 | 441.795 | 439.489 | 1.936 |
| Retained Earnings (Accumulated Deficit) | -96.403 | -80.64 | -63.951 | -49.447 | -38.734 |
| Other Equity, Total | -0.554 | -0.184 | -0.009 | -0.01 | 0.002 |
| Total Liabilities & Shareholders’ Equity | 384.673 | 398.45 | 385.347 | 393.275 | 76.148 |
| Total Common Shares Outstanding | 124.457 | 124.303 | 124.094 | 124.094 | 124.094 |
| Long Term Investments | 24.918 | 16.371 | 26.627 | 15.266 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Čisti prihodki/začetna postavka | -50.315 | ||
| Denarna sredstva iz poslovanja | -39.241 | ||
| Denarna sredstva iz poslovanja | 1.019 | ||
| Nedenarne postavke | 10.077 | ||
| Spremembe v obratnem kapitalu | -0.022 | ||
| Denarna sredstva pri naložbenju | -138.964 | ||
| Kapitalski izdatki | -2.269 | ||
| Celotne druge postavke denarnih tokov pri naložbenju | -136.695 | ||
| Denarna sredstva pri financiranju | 327.447 | ||
| Postavke denarnega toka pri financiranju | 327.28 | ||
| Izdaja (odplačilo) delnic, neto | 0.167 | ||
| Neto sprememba denarnih sredstev | 149.242 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -15.763 | -50.315 | -33.626 | -19.122 | -8.409 |
| Cash From Operating Activities | -12.335 | -39.241 | -28.722 | -14.545 | -6.253 |
| Cash From Operating Activities | 0.281 | 1.019 | 0.756 | 0.479 | 0.214 |
| Non-Cash Items | 2.661 | 10.077 | 6.811 | 4.129 | 1.864 |
| Changes in Working Capital | 0.486 | -0.022 | -2.663 | -0.031 | 0.078 |
| Cash From Investing Activities | 15.182 | -138.964 | -145.028 | -61.048 | 23.518 |
| Other Investing Cash Flow Items, Total | 15.663 | -136.695 | -143.745 | -60.035 | 23.518 |
| Cash From Financing Activities | 0.156 | 327.447 | 327.384 | 327.373 | -2.069 |
| Financing Cash Flow Items | 0 | 327.28 | 327.28 | 327.327 | -2.069 |
| Net Change in Cash | 3.003 | 149.242 | 153.634 | 251.78 | 15.196 |
| Capital Expenditures | -0.481 | -2.269 | -1.283 | -1.013 | |
| Issuance (Retirement) of Stock, Net | 0.156 | 0.167 | 0.104 | 0.046 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Mallick (Parag) | Individual Investor | 16.5616 | 20679892 | 200000 | 2022-04-18 | LOW |
| Patel (Sujal M) | Individual Investor | 13.7018 | 17108999 | 0 | 2023-02-27 | LOW |
| Perceptive Advisors LLC | Private Equity | 7.2967 | 9111151 | 0 | 2022-12-31 | MED |
| Cercano Management LLC | Investment Advisor | 5.7445 | 7172985 | 7172985 | 2022-12-31 | |
| Vulcan Capital Management Inc | Corporation | 5.7445 | 7172985 | 0 | 2022-04-18 | |
| Madrona Venture Group, LLC | Venture Capital | 4.8218 | 6020770 | 0 | 2022-12-31 | LOW |
| ARYA Sciences Holdings III | Corporation | 3.3207 | 4146500 | 3647500 | 2022-04-18 | |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.1231 | 2651020 | 144356 | 2022-12-31 | LOW |
| Comprehensive Financial Management LLC | Investment Advisor | 1.7816 | 2224619 | 0 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.7422 | 2175376 | -1313 | 2022-12-31 | LOW |
| Bain Capital Life Sciences Investors, LLC | Investment Advisor | 1.6017 | 2000000 | 0 | 2022-12-31 | LOW |
| Nazem (Farzad) | Individual Investor | 1.5121 | 1888146 | 0 | 2022-04-18 | LOW |
| Tikvah Management LLC | Hedge Fund | 1.1924 | 1488895 | 0 | 2022-12-31 | LOW |
| Amazon.com Inc | Investment Advisor | 1.1669 | 1457055 | 0 | 2022-12-31 | LOW |
| ArchPoint Investors, LLC | Investment Advisor | 1.1609 | 1449551 | 0 | 2022-12-31 | LOW |
| Andreessen Horowitz | Venture Capital | 1.0859 | 1355911 | -16298006 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7695 | 960868 | 5799 | 2022-12-31 | LOW |
| Rubric Capital Management LP | Hedge Fund | 0.5987 | 747607 | 0 | 2022-12-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.5624 | 702204 | 49879 | 2022-12-31 | LOW |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 0.4805 | 600000 | 0 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Nautilus Biotechnology, Inc. Company profile
O družbi Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. je podjetje v razvojni fazi na področju znanosti o življenju. Podjetje se ukvarja z ustvarjanjem platformne tehnologije za kvantifikacijo in odkrivanje kompleksnosti človeškega proteoma. Podjetje se osredotoča na preoblikovanje področja proteomike z demokratizacijo dostopa do proteoma in omogočanjem temeljnega napredka na področju človeškega zdravja in medicine. Njena celovita platformna rešitev je sestavljena iz sistema za analizo proteoma, potrošnega materiala in programske opreme. Podjetje razvija prototip enomolekularnega instrumenta, sistema za proteomsko analizo. Družbena platforma za proteomsko analizo uporablja nanoizdelano enomolekularno proteinsko matriko, večciklično slikanje in analizo s strojnim učenjem za občutljivo in obsežno prepoznavanje in merjenje proteoma.
| Industry: | Biotechnology & Medical Research (NEC) |
2701 Eastlake Ave East
Suite 202
SEATTLE
WASHINGTON 98102
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com